Control of bone growth by fibroblast growth factors

Trends in Endocrinology and Metabolism

Volumn 10, Issue 2, 1999, Pages 61-65

  De Luca, Francesco ^a   Baron, Jeffrey ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DYSPLASIA; BONE GROWTH; CARTILAGE CELL; CARTILAGE MATRIX; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; GENE MUTATION; GROWTH PLATE; GROWTH REGULATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORGAN CULTURE; OSSIFICATION; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0032996450     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00120-9     Document Type: Review

References (44)

1. Howell, D.S. and Dean, D.D. (1992) The biology, chemistry, and biochemistry of the mammalian growth plate. In Disorders of Bone and Mineral Metabolism (Coe, F.L. and Favus, M.J., eds), pp 313-353, Raven Press.
2. Hunziker E.B. Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc. Res. Tech. 28:1994;505-519.
3. Farnum C.E., Wilsman N.J. Morphologic stages of the terminal hypertrophic chondrocyte of growth plate cartilage. Anat. Rec. 219:1987;221-232.
4. Aharinejad S.et al. Microvascular pattern in the metaphysis during bone growth. Anat. Rec. 242:1995;111-122.
5. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18:1997;26-45.
6. Burke D.et al. Fibroblast growth factor receptors: lessons from the genes. Trends Biochem. Sci. 23:1998;59-62.
7. Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67:1991;229-231.
8. Su W.C.et al. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 386:1997;288-291.
9. Kanai M., Goke M., Tsunekawa S., Podolsky D.K. Signal transduction pathway of human fibroblast growth factor receptor 3. J. Biol. Chem. 272:1997;6621-6628.
10. Kilkenny D.M., Hill D.J. Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrinology. 137:1996;5078-5089.
11. Laufer E., Nelson C.E., Johnson B.A., Morgan B.A., Tabin C. Sonic hedgehog and FGF-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell. 79:1994;993-1003.
12. Peters K., Werner S., Chen G., Williams L.T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development. 114:1992;233-243.
13. Gonzalez A.M., Buscaglia M., Ong M., Baird A. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J. Cell Biol. 110:1990;753-765.
14. Gonzalez A.M., Hill D.J., Maher P.A., Baird A. Distribution of fibroblast growth factor (FGF)-2 and FGF receptor 1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr. Res. 39:1996;375-385.
15. Peters K., Ornitz D., Werner S., Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155:1993;423-430.
16. Hill, D.J., Logan, A., Gonzalez, A.M. and Delhanty, P. (1993) Distinct anatomical sites of expression and distribution of peptide growth factors during epiphyseal chondrogenesis. 75th Annual Meeting of the Endocrine Society, p. 177 (Abstr.).
17. Rimoin D.L., Silbergerg R., Hollister D.W. Chondro-osseous pathology in the chondrodystrophies. Clin. Orthopaed. Related Res. 114:1976;137-152.
18. Shiang R., Thompson L.M., Zhu Y.Z.et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78:1994;335-342.
19. Tavormina P.et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:1995;321-328.
20. Bellus G.A.et al. A recurrent mutation in tyrosine kinase domain of fibroblast growth factor 3 causes hypochondroplasia. Nat. Genet. 10:1995;357-359.
21. Jabs E.W.et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8:1994;275-279.
22. Wilkie A.O.M.et al. Apert syndrome results from localised mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9:1995;165-172.
23. Rutland P.et al. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat. Genet. 9:1995;173-176.
24. Webster M.K., Donoghue D.J. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:1996;520-527.
25. Neilson K.M., Friesel R. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J. Biol. Chem. 271:1996;25049-25057.
26. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
27. Colvin J.S., Bohne B.A., Harding G.W., McEwen D.G., Ornitz D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12:1996;390-397.
28. Coffin J.D.et al. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6:1995;1861-1873.
29. Nagai H., Tsukuda R., Mayahara H. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. J. Bone Miner. Res. 16:1995;367-373.
30. Iwamoto M., Shimazu A., Nakashima K., Suzuki F., Kato Y. Reduction in basic fibroblast growth factor receptor is coupled with terminal differentiation of chondrocytes. J. Biol. Chem. 266:1991;461-467.
31. Trippel S.B., Wrobleski J., Makower A.M., Whelan N.C., Schoenfeld D., Doctrow S.R. Regulation of growth-plate chondrocytes by insulin-like growth-factor I and basic fibroblast growth factor. J. Bone Joint Surg. 75a:1993;177-189.
32. Crabb I.D., O'Keefe R.J., Puzas J.E., Rosier R.N. Synergistic effect of transforming growth factor β and fibroblast growth factor on DNA synthesis in chick growth plate chondrocytes. J. Bone Miner. Res. 5:1990;1105-1112.
33. Froger-Gaillard B., Charrier A.M., Thenet S., Ronet X., Adolphe M. Growth-promoting effects of acidic and basic fibroblast growth factor on rabbit articular chondrocytes of aging in culture. Exp. Cell Res. 183:1989;388-398.
34. Rosselot G., Vasilatos-Younken R., Leach R.M. Effect of growth hormone, insulin-like growth factor I, basic fibroblast growth factor, and transforming growth factor β on cell proliferation and proteoglycan synthesis by avian postembryonic growth plate chondrocytes. J. Bone Miner. Res. 9:1994;431-439.
35. Makower A.M., Wrobleski J., Pawlowski A. Effects of IGF-I, rGH, FGF, EGF, and NCS on DNA synthesis, cell proliferation and morphology of chondrocytes isolated from rat rib growth cartilage. Cell Biol. Int. Rep. 13:1989;259-270.
36. Kato Y., Iwamoto M., Koike T. Fibroblast growth factor stimulates colony formation of differential chondrocytes in soft agar. J. Cell. Physiol. 133:1987;491-498.
37. Hill D.J., Logan A., McGarry M., De Sousa D. Control of protein and matrix molecular synthesis in isolated ovine fetal growth plate chondrocytes by the interactions of basic fibroblast growth factor, insulin-like growth factors-I and -II, insulin and transforming growth factor-β J. Endocrinol. 133:1992;363-373.
38. Inoue H., Kato Y., Iwamoto M., Hiraki Y., Sakuda M., Suzuki F. Stimulation of cartilage matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor β J. Cell. Physiol. 138:1989;329-337.
39. Horton W.E., Higginbotham J.D., Chandrasekhar S. Transforming growth factor-beta and fibroblast growth factor act synergistically to inhibit collagen II synthesis through a mechanism involving regulatory DNA sequences. J. Cell. Physiol. 141:1989;8-15.
40. Hill D.J., Logan A. Peptide growth factors and their interactions during chondrogenesis. Prog. Growth Factor Res. 4:1992;45-68.
41. Mancilla E.E., De Luca F., Uyeda J.A., Czerwiec F.S., Baron J. Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology. 139:1998;2900-2904.
42. Abad, V., Uyeda, J.A., Temple, H.T., De Luca, F. and Baron, J. Determinants of spatial polarity in the growth plate. Endocrinology (in press).
43. Baron J.et al. Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology. 135:1994;2790-2793.
44. Sasse J., Sullivan R., Klagsburn M. Purification of cartilage-derived growth factors. Methods Enzymol. 146:1987;320-325.